This is a demo store. No orders will be fulfilled.

Lebrikizumab (anti-IL-13) - Primary antibody, specific to IL13, >95%, high purity, Human IgG4SP, INHIBITOR of Interleukin-13 inhibitor, INHIBITOR of Interleukin-13 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human
  • Isotype: Human IgG4SP
  • Conjugation: Unconjugated
In stock
Item Number
Ab175900
Grouped product items
SKU Size
Availability
Price Qty
Ab175900-100μg
100μg
10
$49.90
Ab175900-1mg
1mg
4
$249.90
Ab175900-5mg
5mg
1
$649.90
Ab175900-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,029.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Lebrikizumab (anti-IL-13) - Primary antibody, specific to IL13, >95%, high purity, Human IgG4SP, INHIBITOR of Interleukin-13 inhibitor
Synonyms Allergic rhinitis antibody | ALRH antibody | BHR 1 antibody | BHR1 antibody | Bronchial hyperresponsiveness 1 (bronchial asthma) antibody | IL 13 antibody | IL-13 antibody | Il13 antibody | IL13_HUMAN antibody | Interleukin 13 antibody | Interleukin-13 an
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity IL13
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Interleukin-13 inhibitor
Product Description

Lebrikizumab (anti-IL-13) is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab (anti-IL-13) can be used for the research of asthma. 

Purity

>95% (SDS-PAGE&SEC)

Endotoxin Level

< 1.0EU/mg

Product Properties

Isotype Human IgG4SP
Light Chain Type kappa
SDS-PAGE 27.5 kDa (Light Chain) & 53.3 kDa (Heavy Chain), under reducing conditions; 188.1 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 953400-68-5

Associated Targets(Human)

IL13 Tclin Interleukin-13 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Lebrikizumab (anti-IL-13) (Ab175900) - ELISA
Immobilized Recombinant Human IL-13 Protein (rp147396) at 2.0 μg/mL can bind Lebrikizumab (anti-IL-13) (Ab175900) with the EC₅₀ of 325.8 ng/mL.

Lebrikizumab (anti-IL-13) (Ab175900) - SEC
The purity of Lebrikizumab (anti-IL-13) (Ab175900) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0404244 Certificate of Analysis Apr 08, 2024 Ab175900
ZJ24F0404243 Certificate of Analysis Apr 08, 2024 Ab175900
ZJ24F0404242 Certificate of Analysis Apr 08, 2024 Ab175900

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.